Sing Yu Moorcraft

3.8k total citations · 1 hit paper
17 papers, 997 citations indexed

About

Sing Yu Moorcraft is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Sing Yu Moorcraft has authored 17 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Surgery and 7 papers in Cancer Research. Recurrent topics in Sing Yu Moorcraft's work include Cancer Genomics and Diagnostics (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Genetic factors in colorectal cancer (3 papers). Sing Yu Moorcraft is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Gastric Cancer Management and Outcomes (4 papers) and Genetic factors in colorectal cancer (3 papers). Sing Yu Moorcraft collaborates with scholars based in United Kingdom, United States and Netherlands. Sing Yu Moorcraft's co-authors include Ian Chau, David Cunningham, Ravi Shridhar, Bassel F. El‐Rayes, Peter J. Allen, Jason E. Faris, Peter J. Hosein, Casper H.J. van Eijck, Jill Lacy and Bas Groot Koerkamp and has published in prestigious journals such as The Lancet Oncology, Annals of Oncology and BMC Cancer.

In The Last Decade

Sing Yu Moorcraft

17 papers receiving 980 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

2016 653 citations Mustafa Suker, Berend R. Beumer et al. The Lancet Oncology profile →

Peers

Countries citing papers authored by Sing Yu Moorcraft

Since Specialization

Citations

This map shows the geographic impact of Sing Yu Moorcraft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sing Yu Moorcraft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sing Yu Moorcraft more than expected).

Fields of papers citing papers by Sing Yu Moorcraft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sing Yu Moorcraft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sing Yu Moorcraft. The network helps show where Sing Yu Moorcraft may publish in the future.

Co-authorship network of co-authors of Sing Yu Moorcraft

This figure shows the co-authorship network connecting the top 25 collaborators of Sing Yu Moorcraft. A scholar is included among the top collaborators of Sing Yu Moorcraft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sing Yu Moorcraft. Sing Yu Moorcraft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Case Report: Response to ipilimumab and nivolumab in a patient with adrenocortical carcinoma 2023 ·Frontiers in Oncology ·Rebecca L. Charles, (unknown), (unknown), (unknown), Owen Hughes, Nagappan Kumar, Sing Yu Moorcraft	1
2	P-138 A comparison of the transcriptomic profiles of matched tissue from primary colorectal cancer and corresponding secondary lung metastases 2020 ·Annals of Oncology ·Shelize Khakoo, Sing Yu Moorcraft, Alain Pacis, Marc Münter, Mark Lathrop, François Lefebvre, Yasser Riazalhosseini, (unknown), Thomas R. Jones, Ruwaida Begum, Andrew Wotherspoon, Claire Saffery, Eleftheria Kalaitzaki, Hima Anbunathan, Sheela Rao, David Watkins, Naureen Starling, David Cunningham, Ian Chau, A. Bowcock	1
3	A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer 2016 ·HPB ·Mustafa Suker, Eran Sadot, Lysiane Marthey, Sing Yu Moorcraft, Thierry Conroy, Bassel F. El‐Rayes, Jason E. Faris, Jill Lacy, Eric A. Mellon, Casper H.J. van Eijck, Bas Groot Koerkamp	5
4	Patients’ willingness to participate in clinical trials and their views on aspects of cancer research: results of a prospective patient survey 2016 ·Trials ·Sing Yu Moorcraft, Cheryl Marriott, Clare Peckitt, David Cunningham, Ian Chau, Naureen Starling, David Watkins, Sheela Rao	140
5	Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study 2016 ·BMC Cancer ·Sing Yu Moorcraft, Elisa Fontana, David Cunningham, Clare Peckitt, Thomas K. Waddell, Elizabeth Smyth, William Allum, J N Thompson, Sheela Rao, David Watkins, Naureen Starling, Ian Chau	14
6	Does cancer research focus on areas of importance to patients? 2016 ·ecancermedicalscience ·Sing Yu Moorcraft, (unknown), Clare Peckitt, (unknown), (unknown), Natalie Pattison, Theresa Wiseman	3
7	FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis breakdown → 2016 ·The Lancet Oncology ·Mustafa Suker, Berend R. Beumer, Eran Sadot, Lysiane Marthey, Jason E. Faris, Eric A. Mellon, Bassel F. El‐Rayes, Andrea Wang‐Gillam, Jill Lacy, Peter J. Hosein, Sing Yu Moorcraft, Thierry Conroy, Florian Hohla, Peter J. Allen, Julien Taı̈eb, Theodore S. Hong, Ravi Shridhar, Ian Chau, Casper H.J. van Eijck, Bas Groot Koerkamp	653
8	Attitudes of Patients With Gastrointestinal Cancers Toward Research Biopsies 2016 ·Clinical Colorectal Cancer ·Sing Yu Moorcraft, Ruwaida Begum, David Cunningham, Clare Peckitt, Chiara Baratelli, Angela Gillbanks, (unknown), (unknown), Ian Chau, David Watkins, Naureen Starling	4
9	A patient-level meta-analysis of FOLFIRINOX for locally advanced pancreatic cancer. 2016 ·Pancreatology ·Mustafa Suker, Berend R. Beumer, Eran Sadot, Lysiane Marthey, Jason E. Faris, Eric A. Mellon, Bassel F. El‐Rayes, Andrea Wang‐Gillam, Jill Lacy, Peter J. Hosein, Sing Yu Moorcraft, Thierry Conroy, Florian Hohla, Peter J. Allen, Julien Taı̈eb, Theodore S. Hong, Ravi Shridhar, Ian Chau, Casper H.J. van Eijck, Bas Groot Koerkamp	2
10	Understanding next generation sequencing in oncology: A guide for oncologists 2015 ·Critical Reviews in Oncology/Hematology ·Sing Yu Moorcraft, David González, Brian A. Walker	29
11	Management of resectable colorectal lung metastases 2015 ·Clinical & Experimental Metastasis ·Sing Yu Moorcraft, George Ladas, A. Bowcock, Ian Chau	27
12	FOLFIRINOX for Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: The Royal Marsden Experience 2014 ·Clinical Colorectal Cancer ·Sing Yu Moorcraft, Khurum Khan, Clare Peckitt, David Watkins, Sheela Rao, David Cunningham, Ian Chau	53
13	Adjuvant or neoadjuvant therapy for operable esophagogastric cancer? 2014 ·Gastric Cancer ·Sing Yu Moorcraft, Elizabeth Smyth, David Cunningham	25
14	Investigational therapies targeting the ErbB family in oesophagogastric cancer 2014 ·Expert Opinion on Investigational Drugs ·Sing Yu Moorcraft, Ian Chau	4
15	Potential Role of Rilotumumab in the Treatment of Gastric Cancer 2014 ·Immunotherapy ·Thomas K. Waddell, Sing Yu Moorcraft, David Cunningham	3
16	Patupilone in patients with pretreated metastatic/locally recurrent colorectal cancer: results of the Phase II CINATRA trial 2013 ·Investigational New Drugs ·Sing Yu Moorcraft, Ian Chau, Clare Peckitt, David Cunningham, Shuan Rao, (unknown), Axel Walther, Christopher Jackson, Gordon Stamp, (unknown), (unknown), Angela Gillbanks, Charles Swanton	7
17	The role of personalized medicine in metastatic colorectal cancer: an evolving landscape 2013 ·Therapeutic Advances in Gastroenterology ·Sing Yu Moorcraft, Elizabeth Smyth, David Cunningham	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact